Soraiya Verjee, Business Development Director of Sea Monster, discusses how the use of games and animation can combat COVID-19 and vaccine misinformation.
France and Greece both made statements yesterday (12 July) declaring that the COVID vaccine was now mandatory for healthcare workers - with French workers losing wages after September, if they don't have a dose.
SAGE reveal that in the most pessimistic scenario, a further 115,800 COVID deaths would happen by June, 2022 - but in the most optimistic 'unlockdown' output, the figure is 9,400 deaths.
The FDA have labelled the Johnson & Johnson COVID vaccine as a possible cause of Guillain-Barré syndrome - an extremely rare side effect that can potentially cause nerve damage.
An Australian team found that antibodies created by infection with the virus are not effective against COVID variants - suggesting that vaccination gives stronger protection.
Arthur Goudena, Marketing Manager of PHC Europe, explains how the company’s cold storage solutions are available to support COVID-19 vaccination campaigns across Europe.
The Lambda variant, originating in Peru, has been found in 32 countries - but for the moment, it remains classified as a less threatening Variant of Interest.
SAGE say the UK Governments' plans to lift all social distancing measures on 19 July are too much - they believe a rise in infections will increase ethnic minority COVID deaths.
While mRNA is now well-connected to Pfizer or Moderna, saRNA is a more obscure, early-stage vaccine technology - now, scientists in the UK have data suggesting that saRNA COVID vaccines could work well for most people.
A study released yesterday (28 June) found that it would be safe to mix Pfizer and AstraZeneca doses, which could speed up UK vaccine roll-out if adopted.
The World Health Organisation says that double-vaccinated people should wear masks due to the rising threat of the Delta variant, as the UK considers dropping mandatory mask measures after 'unlockdown'.
The UK Government will begin rollout of a third COVID dose for over-50s and vulnerable individuals, with the NHS given the go-ahead to create their pre-winter vaccination plan.
According to the US and Swiss study, 94% of cancer patients took the COVID vaccine in full and produced antibodies - while seven high-risk patients failed to produce an immune response.
